Cloverdale Capital Management Portfolio holdings
Top Buys
| 1 |
Avanos Medical
AVNS
|
+$15.2M |
| 2 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$14M |
| 3 |
TSE
Trinseo
TSE
|
+$13.5M |
| 4 |
World Acceptance Corp
WRLD
|
+$11.8M |
| 5 |
8x8 Inc
EGHT
|
+$9.37M |
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
+$15.4M |
| 2 |
Brink's
BCO
|
+$14M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$12M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.9M |
| 5 |
Extreme Networks
EXTR
|
+$10.9M |
Sector Composition
| 1 | Industrials | 24.86% |
| 2 | Consumer Discretionary | 19.02% |
| 3 | Communication Services | 10.69% |
| 4 | Technology | 9.55% |
| 5 | Consumer Staples | 8.72% |
Similar funds
Cloverdale Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Cloverdale Capital Management held 35 positions worth $208M, up 16% from $179M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Cloverdale Capital Management deployed $18.9M of net new capital in Q2 2018, opening 11 new positions and adding to 6 existing holdings. Its largest new stake was Avanos Medical: 287,499 shares worth $16.5M.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Keysight, an estimated $8.13M trimmed.
- Cloverdale Capital Management's largest Q2 2018 buy was Avanos Medical: 287,499 shares worth $16.5M.
- Cloverdale Capital Management added most to Woodward in Q2 2018, an estimated $8.08M increase.
- Cloverdale Capital Management's biggest Q2 2018 reduction was Keysight, cutting an estimated $8.13M.
- Cloverdale Capital Management fully exited Tech Data Corp in Q2 2018, selling an estimated $15.4M.
- Cloverdale Capital Management's ten largest holdings make up 72% of its $208M portfolio in Q2 2018.
- Cloverdale Capital Management opened 11 new positions and closed 16 in Q2 2018.
- Cloverdale Capital Management's portfolio value rose 16% quarter-over-quarter to $208M.
Based on Cloverdale Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.